Evidence map›Paper›PMID 40672174›Full record

ArticlebioRxiv : the preprint server for biology2025

Identification and characterization of functional and trans-dominant negative HERV-K (HML-2) Rec proteins encoded in the human genome.

Katarzyna Zurowska, Godfrey Dzhivhuho, David Grabski, David Rekosh, Marie-Louise Hammarskjold

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Katarzyna ZurowskaMyles H. Thaler Center for AIDS and Human Retrovirus Research, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Godfrey DzhivhuhoMyles H. Thaler Center for AIDS and Human Retrovirus Research, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
David GrabskiMyles H. Thaler Center for AIDS and Human Retrovirus Research, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
David RekoshMyles H. Thaler Center for AIDS and Human Retrovirus Research, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0003-3662-4176
Marie-Louise HammarskjoldMyles H. Thaler Center for AIDS and Human Retrovirus Research, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
HIV, HERV-K and Human CancerR01CA206275 · NCI · UNIVERSITY OF VIRGINIA · PI HAMMARSKJOLD, MARIE-LOUISE, REKOSH, DAVID M · 2017 to 2021
$2.2M
NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA206275
6 · The paper itself

Abstract

Human Endogenous Retroviruses K (HERV-K) of the HML-2 subgroup are the most recently integrated and biologically active retroviral elements within the human genome. The HERV-K Rec protein, a functional homolog of HIV Rev and HTLV Rex, is necessary for the nuclear export of viral mRNAs with retained introns. However, the diversity of Rec proteins encoded in the human genome and their functional capacities have remained largely unexplored. We identified full-length Rec protein sequences in the human genome and selected 23 variants for functional characterization. Using a dual-color fluorescent reporter and a complementary ELISA assay, we found that Rec proteins from only 7 genomic loci were functional. In addition, a subset of the non-functional Rec proteins exerted trans-dominant negative effects. Detailed mutational analysis of the most potent inhibitory variant, encoded by the HERV-K provirus 12q14.1, displayed only 2 amino acid changes (H2N and del34E) relative to the prototypical functional Rec protein encoded by the reconstructed consensus HERV-K (HERV-K Con). Insertion of a glutamic acid at position 34 restored the functional activity, while the substitution of histidine with asparagine at position 2 did not. Our results unveil an unexpected complexity in HERV-K (HML-2) post-transcriptional regulation, with Rec variants displaying a spectrum of activities ranging from robust nuclear export of RNA with retained introns to trans-dominant negative inhibition of Rec function. These findings expand our understanding of the regulatory landscape governing HERV-K (HML-2) expression and suggest mechanisms by which different HERV-K Rec proteins may influence host cell biology and pathology, including oncogenesis.

Identifiers

PMID40672174
PMCPMC12265724

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.